Viewing Study NCT04635735


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-01-03 @ 6:27 AM
Study NCT ID: NCT04635735
Status: TERMINATED
Last Update Posted: 2023-03-23
First Post: 2020-11-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ipilimumab View
None Stem Cell Transplantation View
None 20-329 View